The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing treatment on the NHS. Ms Mehta, 36, from London, suffers from beta thalassaemia, a ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

Hematologists are internal medicine doctors or pediatricians who have extra training in disorders related to your blood, bone marrow, and lymphatic system. They’re specialists who may work in ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a ...

Hematologic disorders comprise a vast category of diseases that affect millions of Americans and have a significant impact on the lives of individuals, their loved ones and the U.S. healthcare system ...

The Tri-State’s TRUSTED news source. Click here to stay informed and subscribe to Herald-Dispatch. Click #isupportlocal for more information on supporting our local journalists. Diseases and disorders ...

Just as the COVID-19 pandemic forced the annual meeting of the American Society of Hematology to go virtual to keep its 30,000 participants safe, it threw up roadblocks to research in labs and clinics ...

A hematologist oncologist is a doctor who specializes in treating cancers of the blood. They have extra training in the blood system, lymphatic system, bone marrow, and cancers. The term “hematologist ...

Yazan Abou-Ismail, MD (Mouhamed Yazan Abou-Ismail) is an Associate Professor of Medicine at the Division of Hematology and Hematologic Malignancies, and board-certified Hematologist and Internist. He ...

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders.